Nano PharmaSolutions

Nano PharmaSolutions

Life Science Nation Interviews CEO Dr. Kay Olmstead.

  • Edit
Get premium to view all results
DateInvestorsAmountRound
-investor investor

€0.0

round
N/A

€0.0

round
investor

€0.0

round
investor

€0.0

round

N/A

Seed
Total Funding000k
Notes (0)
More about Nano PharmaSolutions
Made with AI
Edit

Nano PharmaSolutions specializes in enhancing the bioavailability of poorly soluble drugs through innovative nanoformulation techniques. The company operates in the pharmaceutical and biotechnology sectors, focusing on rapid formulation development for first-in-human (FIH) studies. Nano PharmaSolutions serves pharmaceutical companies and research institutions looking to improve the efficacy of their drug candidates. The business model revolves around providing comprehensive, cost-effective solutions for drug formulation, which includes developing dry powder inhalation (DPI) formulations like remdesivir for early-stage COVID-19 treatment. Revenue is generated through partnerships and service contracts with pharmaceutical firms seeking to enhance their drug development processes.

Keywords: nanoformulation, bioavailability, insoluble drugs, pharmaceutical, biotechnology, drug development, FIH studies, DPI formulation, COVID-19, remdesivir.

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads